These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

736 related items for PubMed ID: 9356033

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial.
    Diabetes; 1996 Oct; 45(10):1289-98. PubMed ID: 8826962
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial.
    Diabetes; 1995 Aug; 44(8):968-83. PubMed ID: 7622004
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Baseline analysis of renal function in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group [corrected].
    Molitch ME, Steffes MW, Cleary PA, Nathan DM.
    Kidney Int; 1993 Mar; 43(3):668-74. PubMed ID: 8455366
    [Abstract] [Full Text] [Related]

  • 8. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study.
    Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group.
    JAMA; 2003 Oct 22; 290(16):2159-67. PubMed ID: 14570951
    [Abstract] [Full Text] [Related]

  • 9. Apolipoprotein C-III protein concentrations and gene polymorphisms in Type 1 diabetes: associations with microvascular disease complications in the DCCT/EDIC cohort.
    Klein RL, McHenry MB, Lok KH, Hunter SJ, Le NA, Jenkins AJ, Zheng D, Semler A, Page G, Brown WV, Lyons TJ, Garvey WT, DCCT/EDIC Research Group.
    J Diabetes Complications; 2005 Oct 22; 19(1):18-25. PubMed ID: 15642486
    [Abstract] [Full Text] [Related]

  • 10. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy.
    Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group, Lachin JM, Genuth S, Cleary P, Davis MD, Nathan DM.
    N Engl J Med; 2000 Feb 10; 342(6):381-9. PubMed ID: 10666428
    [Abstract] [Full Text] [Related]

  • 11. Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT).
    White NH, Cleary PA, Dahms W, Goldstein D, Malone J, Tamborlane WV, Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group.
    J Pediatr; 2001 Dec 10; 139(6):804-12. PubMed ID: 11743505
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type 1 diabetes mellitus: a 5 year follow-up study of 442 adult patients in routine care.
    Agardh CD, Agardh E, Torffvit O.
    Diabetes Res Clin Pract; 1997 Mar 10; 35(2-3):113-21. PubMed ID: 9179466
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Different patterns of insulin resistance in relatives of type 1 diabetic patients with retinopathy or nephropathy: the Genesis France-Belgium Study.
    Hadjadj S, Péan F, Gallois Y, Passa P, Aubert R, Weekers L, Rigalleau V, Bauduceau B, Bekherraz A, Roussel R, Dussol B, Rodier M, Marechaud R, Lefebvre PJ, Marre M, Genesis France-Belgium Study.
    Diabetes Care; 2004 Nov 10; 27(11):2661-8. PubMed ID: 15505002
    [Abstract] [Full Text] [Related]

  • 17. Heritability of the severity of diabetic retinopathy: the FIND-Eye study.
    Arar NH, Freedman BI, Adler SG, Iyengar SK, Chew EY, Davis MD, Satko SG, Bowden DW, Duggirala R, Elston RC, Guo X, Hanson RL, Igo RP, Ipp E, Kimmel PL, Knowler WC, Molineros J, Nelson RG, Pahl MV, Quade SR, Rasooly RS, Rotter JI, Saad MF, Scavini M, Schelling JR, Sedor JR, Shah VO, Zager PG, Abboud HE, Family Investigation of Nephropathy and Diabetes Research Group.
    Invest Ophthalmol Vis Sci; 2008 Sep 10; 49(9):3839-45. PubMed ID: 18765632
    [Abstract] [Full Text] [Related]

  • 18. Effect of pregnancy on microvascular complications in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group.
    Diabetes Control and Complications Trial Research Group.
    Diabetes Care; 2000 Aug 10; 23(8):1084-91. PubMed ID: 10937502
    [Abstract] [Full Text] [Related]

  • 19. Effects of Prior Intensive Insulin Therapy and Risk Factors on Patient-Reported Visual Function Outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Cohort.
    Writing Team for the DCCT/EDIC Research Group, Gubitosi-Klug RA, Sun W, Cleary PA, Braffett BH, Aiello LP, Das A, Tamborlane W, Klein R.
    JAMA Ophthalmol; 2016 Feb 10; 134(2):137-45. PubMed ID: 26584339
    [Abstract] [Full Text] [Related]

  • 20. Prevalence and associated features of albuminuria in Koreans with NIDDM.
    Lee KU, Park JY, Kim SW, Lee MH, Kim GS, Park SK, Park JS.
    Diabetes Care; 1995 Jun 10; 18(6):793-9. PubMed ID: 7555505
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.